5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Free radical biology & medicine, 2019-04, Vol.134, p.288 [Peer Reviewed Journal]Copyright © 2019. Published by Elsevier Inc. ;EISSN: 1873-4596 ;DOI: 10.1016/j.freeradbiomed.2019.01.003 ;PMID: 30615919
Digital Resources/Online E-Resources